Mechanism of levosimendan in treating hypoxic pulmonary hypertension based on network pharmacology and molecular docking technology
- Author:
Xiao-Dan ZHANG
1
;
Yu-Liang XIE
1
;
Meng-Dan GAO
1
;
Ao-Xue YUAN
1
;
Han-Fei LI
1
;
Tian-Tian ZHU
1
;
Xiao-Dan ZHANG
2
;
Yu-Liang XIE
2
;
Meng-Dan GAO
2
;
Ao-Xue YUAN
2
;
Han-Fei LI
2
;
Tian-Tian ZHU
2
;
Xiao-Dan ZHANG
3
;
Yu-Liang XIE
3
;
Meng-Dan GAO
3
;
Ao-Xue YUAN
3
;
Han-Fei LI
3
;
Tian-Tian ZHU
3
Author Information
- Publication Type:Journal Article
- Keywords: animal experiments; hypoxic pulmonary hypertension; levosimendan; mechanism of action; molecular docking; network pharmacology
- From: Chinese Pharmacological Bulletin 2024;40(3):565-573
- CountryChina
- Language:Chinese
- Abstract: Aim To explore the efficacy of levosimendan on hypoxia pulmonary hypertension through animal experiments, and to further explore the potential mechanism of action using network pharmacological methods and molecular docking technique. Methods The rat model of hypoxia pulmonary hypertension was constructed to detect right heart systolic pressure and right heart remodeling index. HE , Masson, and VG staining were core targets were screened out. GO and KEGG pathway enrichment analysis were performed using the DAVID database. Molecular docking of the core targets was performed with the AutoDock software. Results The results of animal experiments showed that levosimendan had obvious therapeutic effect on hypoxia pulmonary hypertension. The network pharmacology results showed that SRC, HSP90AA1, MAPK1, PIK3R1, AKT1, HRAS, MAPK14, LCK, EGFR and ESR1 used to analyze the changes of rat lung histopathology. Search the Swiss Target Prediction, DrugBank Online, BatMan, Targetnet, SEA, and PharmMapper databases were used to screen for drug targets. Disease targets were retrieved from the GeneCards, OMIM databases. The "drug-target-disease" network was constructed after identification of the two intersection targets. The protein interaction network was constructed and the were the key targets to play a therapeutic role. Molecular docking showed good docking of levosimendan with all the top five core targets with degree values. Conclusions Levosimendan may exert a therapeutic effect on hypoxia-induced pulmonary hypertension through multiple targets.
